High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

BACKGROUND: The effective treatment of coronavirus disease 2019 (COVID-19) remains unclear. We reported successful use of high-dose intravenous immunoglobulin (IVIg) in cases of severe COVID-19, but evidence from larger case series is still lacking. METHODS: A multi-center retrospective study was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Liu, Xiaosheng, Hong, Ke, Ma, Zhiyong, Zhang, Yuelun, Lin, Ling, Han, Yang, Xiong, Yong, Liu, Zhengyin, Ruan, Lianguo, Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933558/
https://www.ncbi.nlm.nih.gov/pubmed/33679771
http://dx.doi.org/10.3389/fimmu.2021.627844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933558/
https://www.ncbi.nlm.nih.gov/pubmed/33679771
http://dx.doi.org/10.3389/fimmu.2021.627844

Ejemplares similares